Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study. (Q40468678)
Jump to navigation
Jump to search
scientific article published on October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study. |
scientific article published on October 2006 |
Statements
1 reference
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study. (English)
1 reference
Edward Stadtmauer
1 reference
James R Berenson
1 reference
Ralph Boccia
1 reference
David Siegel
1 reference
Marek Bozdech
1 reference
Alberto Bessudo
1 reference
J Talisman Pomeroy
1 reference
Ronald Steis
1 reference
Marshall Flam
1 reference
Jose Lutzky
1 reference
Syed Jilani
1 reference
Joseph Volk
1 reference
Siu-Fun Wong
1 reference
Robert Moss
1 reference
Ravi Patel
1 reference
Delina Ferretti
1 reference
Kit Russell
1 reference
Robert Louie
1 reference
Howard S Yeh
1 reference
Regina A Swift
1 reference
1 October 2006
1 reference
1 reference
135
1 reference
2
1 reference
174-183
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference